Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2013 May 9;23(11):10.1016/j.euroneuro.2013.03.003. doi: 10.1016/j.euroneuro.2013.03.003

Table 4.

P3a/b measures on the novelty auditory oddball task in antidepressant treatment responders, non-responders and controls (mean ± standard error)

ERP Measure Controls
(N=43)		 Responders
(N=26)		 Non-
Responders
(N=25)		 Females
(N=52)		 Males
(N=44)
P3a Amplitude (µV) 9.2 ± 0.6 8.71 ± 0.71 6.9 ± 0.7 9.2 ± 0.5 7.3 ± 0.6
P3a Latency (ms) 319.8 ± 6.3 332.4 ± 8.3 333.5 ± 8.3 325.7 ± 6.1 331.5 ± 6.4
P3b Amplitude (µV) 9.6 ± 0.7 10.0 ± 0.9 7.0 ± 0.9 10.2 ± 0.7 7.6 ± 0.7
P3b Latency (ms) 364.1 ± 6.4 355.2 ± 8.3 362.0 ± 8.3 356.7 ± 6.2 364.2 ± 6.5